Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01BQD
|
|||
| Former ID |
DNC004172
|
|||
| Drug Name |
2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ylamine
|
|||
| Synonyms |
CHEMBL65119
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H17N3O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)OC2=CC=C(C=C2)CC3=NC4=C(N3)C=C(C=C4)N
|
|||
| InChI |
1S/C20H17N3O/c21-15-8-11-18-19(13-15)23-20(22-18)12-14-6-9-17(10-7-14)24-16-4-2-1-3-5-16/h1-11,13H,12,21H2,(H,22,23)
|
|||
| InChIKey |
KVTYWLATLSZWKO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles. J Med Chem. 2004 Apr 8;47(8):2089-96. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.